nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomethadyl Acetate—OPRM1—autistic disorder	0.459	0.586	CbGaD
Levomethadyl Acetate—CYP19A1—autistic disorder	0.325	0.414	CbGaD
Levomethadyl Acetate—OPRM1—telencephalic ventricle—autistic disorder	0.00633	0.15	CbGeAlD
Levomethadyl Acetate—CHRNA3—eye—autistic disorder	0.00274	0.0649	CbGeAlD
Levomethadyl Acetate—CHRNA3—forebrain—autistic disorder	0.00271	0.0644	CbGeAlD
Levomethadyl Acetate—CHRNB4—head—autistic disorder	0.00253	0.0601	CbGeAlD
Levomethadyl Acetate—CHRNB4—nervous system—autistic disorder	0.0024	0.057	CbGeAlD
Levomethadyl Acetate—CHRNB4—central nervous system—autistic disorder	0.00231	0.0548	CbGeAlD
Levomethadyl Acetate—CHRNB4—brain—autistic disorder	0.00183	0.0435	CbGeAlD
Levomethadyl Acetate—OPRM1—brainstem—autistic disorder	0.00171	0.0406	CbGeAlD
Levomethadyl Acetate—OPRM1—forebrain—autistic disorder	0.00165	0.0392	CbGeAlD
Levomethadyl Acetate—CHRNA3—head—autistic disorder	0.00155	0.0369	CbGeAlD
Levomethadyl Acetate—OPRM1—telencephalon—autistic disorder	0.00152	0.0361	CbGeAlD
Levomethadyl Acetate—CHRNA3—nervous system—autistic disorder	0.00147	0.0349	CbGeAlD
Levomethadyl Acetate—CHRNA3—central nervous system—autistic disorder	0.00142	0.0336	CbGeAlD
Levomethadyl Acetate—CYP19A1—forebrain—autistic disorder	0.00139	0.0329	CbGeAlD
Levomethadyl Acetate—CHRNA3—cerebellum—autistic disorder	0.00139	0.0329	CbGeAlD
Levomethadyl Acetate—CHRNA3—brain—autistic disorder	0.00113	0.0267	CbGeAlD
Levomethadyl Acetate—Tamoxifen—DHCR7—autistic disorder	0.00112	0.201	CrCbGaD
Levomethadyl Acetate—OPRM1—head—autistic disorder	0.000946	0.0224	CbGeAlD
Levomethadyl Acetate—OPRM1—nervous system—autistic disorder	0.000897	0.0213	CbGeAlD
Levomethadyl Acetate—Methadyl Acetate—OPRM1—autistic disorder	0.00088	0.158	CrCbGaD
Levomethadyl Acetate—OPRM1—central nervous system—autistic disorder	0.000863	0.0205	CbGeAlD
Levomethadyl Acetate—CYP19A1—head—autistic disorder	0.000795	0.0189	CbGeAlD
Levomethadyl Acetate—Diphenoxylate—OPRM1—autistic disorder	0.00076	0.136	CrCbGaD
Levomethadyl Acetate—CYP19A1—nervous system—autistic disorder	0.000753	0.0179	CbGeAlD
Levomethadyl Acetate—Loperamide—POMC—autistic disorder	0.000732	0.131	CrCbGaD
Levomethadyl Acetate—CYP19A1—central nervous system—autistic disorder	0.000725	0.0172	CbGeAlD
Levomethadyl Acetate—OPRM1—brain—autistic disorder	0.000685	0.0163	CbGeAlD
Levomethadyl Acetate—CYP3A5—digestive system—autistic disorder	0.000629	0.0149	CbGeAlD
Levomethadyl Acetate—CYP19A1—brain—autistic disorder	0.000576	0.0137	CbGeAlD
Levomethadyl Acetate—CYP3A4—digestive system—autistic disorder	0.000472	0.0112	CbGeAlD
Levomethadyl Acetate—CYP3A4—nervous system—autistic disorder	0.000365	0.00867	CbGeAlD
Levomethadyl Acetate—CYP3A4—central nervous system—autistic disorder	0.000352	0.00835	CbGeAlD
Levomethadyl Acetate—Dextropropoxyphene—OPRM1—autistic disorder	0.000331	0.0593	CrCbGaD
Levomethadyl Acetate—Loperamide—OPRM1—autistic disorder	0.000315	0.0565	CrCbGaD
Levomethadyl Acetate—Methadone—HTR3A—autistic disorder	0.000312	0.0559	CrCbGaD
Levomethadyl Acetate—Methadone—OPRM1—autistic disorder	0.000224	0.0402	CrCbGaD
Levomethadyl Acetate—Propiomazine—DRD1—autistic disorder	0.00021	0.0377	CrCbGaD
Levomethadyl Acetate—Phenoxybenzamine—ADRB2—autistic disorder	0.000168	0.0301	CrCbGaD
Levomethadyl Acetate—Tamoxifen—CYP19A1—autistic disorder	0.00016	0.0287	CrCbGaD
Levomethadyl Acetate—Methadone—CYP19A1—autistic disorder	0.000159	0.0284	CrCbGaD
Levomethadyl Acetate—Propiomazine—HTR2A—autistic disorder	0.000115	0.0205	CrCbGaD
Levomethadyl Acetate—Promethazine—HTR2A—autistic disorder	9.65e-05	0.0173	CrCbGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NRP2—autistic disorder	4.07e-05	0.000242	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—AVP—autistic disorder	4.06e-05	0.000241	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—SLC25A12—autistic disorder	4.04e-05	0.00024	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—UPB1—autistic disorder	4.02e-05	0.000238	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—ADM—autistic disorder	3.99e-05	0.000237	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—GABBR1—autistic disorder	3.99e-05	0.000237	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—VIP—autistic disorder	3.96e-05	0.000235	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—GRM5—autistic disorder	3.96e-05	0.000235	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—SLC19A1—autistic disorder	3.93e-05	0.000233	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HTR5A—autistic disorder	3.91e-05	0.000232	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—PDE4B—autistic disorder	3.89e-05	0.000231	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—OXTR—autistic disorder	3.84e-05	0.000228	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—autistic disorder	3.83e-05	0.000228	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—SCT—autistic disorder	3.8e-05	0.000225	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—HRAS—autistic disorder	3.76e-05	0.000223	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ASMT—autistic disorder	3.74e-05	0.000222	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSTM5—autistic disorder	3.74e-05	0.000222	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—GABBR1—autistic disorder	3.62e-05	0.000215	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—ADM—autistic disorder	3.62e-05	0.000215	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—TDO2—autistic disorder	3.56e-05	0.000211	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—POMC—autistic disorder	3.55e-05	0.000211	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—autistic disorder	3.55e-05	0.000211	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	3.54e-05	0.00021	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PDE4B—autistic disorder	3.53e-05	0.00021	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—SLC25A12—autistic disorder	3.51e-05	0.000208	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ADSL—autistic disorder	3.51e-05	0.000208	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—HRAS—autistic disorder	3.44e-05	0.000204	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—XDH—autistic disorder	3.44e-05	0.000204	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—SLC19A1—autistic disorder	3.42e-05	0.000203	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—STX1A—autistic disorder	3.38e-05	0.0002	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—NPAS2—autistic disorder	3.38e-05	0.0002	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—HTR2A—autistic disorder	3.37e-05	0.0002	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—DHCR7—autistic disorder	3.35e-05	0.000199	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—OXT—autistic disorder	3.34e-05	0.000198	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—HTR1B—autistic disorder	3.34e-05	0.000198	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GABBR2—autistic disorder	3.32e-05	0.000197	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—TCN2—autistic disorder	3.26e-05	0.000193	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—EXT1—autistic disorder	3.18e-05	0.000188	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—SLC6A8—autistic disorder	3.18e-05	0.000188	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ADA—autistic disorder	3.11e-05	0.000185	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—autistic disorder	3.11e-05	0.000184	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—DRD1—autistic disorder	3.11e-05	0.000184	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	3.07e-05	0.000182	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ADSL—autistic disorder	3.04e-05	0.000181	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—HTR1B—autistic disorder	3.04e-05	0.00018	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—OXT—autistic disorder	3.04e-05	0.00018	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—DAO—autistic disorder	3.03e-05	0.00018	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—DRD3—autistic disorder	3.01e-05	0.000179	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—XDH—autistic disorder	2.99e-05	0.000177	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HTR1D—autistic disorder	2.96e-05	0.000176	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—IL5—autistic disorder	2.95e-05	0.000175	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	2.94e-05	0.000175	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—STX1A—autistic disorder	2.93e-05	0.000174	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—NPAS2—autistic disorder	2.93e-05	0.000174	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CALCA—autistic disorder	2.91e-05	0.000173	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—UPB1—autistic disorder	2.9e-05	0.000172	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PRLR—autistic disorder	2.85e-05	0.000169	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—RORA—autistic disorder	2.84e-05	0.000168	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—TCN2—autistic disorder	2.83e-05	0.000168	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—DRD1—autistic disorder	2.82e-05	0.000167	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GRM8—autistic disorder	2.75e-05	0.000163	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—CYP19A1—autistic disorder	2.75e-05	0.000163	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—DRD3—autistic disorder	2.73e-05	0.000162	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—CYP19A1—autistic disorder	2.71e-05	0.000161	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ADA—autistic disorder	2.7e-05	0.00016	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ASMT—autistic disorder	2.7e-05	0.00016	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTM5—autistic disorder	2.7e-05	0.00016	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—POMC—autistic disorder	2.69e-05	0.00016	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—IL5—autistic disorder	2.68e-05	0.000159	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—WNT2—autistic disorder	2.67e-05	0.000158	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—MAOB—autistic disorder	2.66e-05	0.000158	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CALCA—autistic disorder	2.64e-05	0.000157	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GHR—autistic disorder	2.63e-05	0.000156	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PDE4A—autistic disorder	2.59e-05	0.000154	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—COMT—autistic disorder	2.55e-05	0.000152	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—GSTP1—autistic disorder	2.54e-05	0.000151	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—SLC25A12—autistic disorder	2.54e-05	0.000151	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—MAOA—autistic disorder	2.54e-05	0.00015	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.53e-05	0.00015	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—COMT—autistic disorder	2.52e-05	0.000149	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—GSTP1—autistic disorder	2.51e-05	0.000149	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—TPH2—autistic disorder	2.47e-05	0.000147	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—SLC19A1—autistic disorder	2.47e-05	0.000147	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—RORA—autistic disorder	2.46e-05	0.000146	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—ADRB2—autistic disorder	2.44e-05	0.000145	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—DPYD—autistic disorder	2.43e-05	0.000144	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—AVPR1A—autistic disorder	2.42e-05	0.000144	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GRM5—autistic disorder	2.34e-05	0.000139	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—VIP—autistic disorder	2.34e-05	0.000139	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—GSTM1—autistic disorder	2.34e-05	0.000139	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—MAOB—autistic disorder	2.31e-05	0.000137	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—GSTM1—autistic disorder	2.3e-05	0.000137	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—AVP—autistic disorder	2.29e-05	0.000136	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.28e-05	0.000135	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—OXTR—autistic disorder	2.27e-05	0.000134	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CACNA1C—autistic disorder	2.26e-05	0.000134	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SCT—autistic disorder	2.24e-05	0.000133	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—ADRB2—autistic disorder	2.21e-05	0.000131	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ADSL—autistic disorder	2.2e-05	0.000131	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—INPP1—autistic disorder	2.19e-05	0.00013	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ACADSB—autistic disorder	2.19e-05	0.00013	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.17e-05	0.000129	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—XDH—autistic disorder	2.16e-05	0.000128	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—TPH2—autistic disorder	2.15e-05	0.000127	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ADM—autistic disorder	2.14e-05	0.000127	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GABBR1—autistic disorder	2.14e-05	0.000127	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NPAS2—autistic disorder	2.12e-05	0.000126	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—STX1A—autistic disorder	2.12e-05	0.000126	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—DPYD—autistic disorder	2.11e-05	0.000125	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—EIF4E—autistic disorder	2.1e-05	0.000125	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PDE4B—autistic disorder	2.09e-05	0.000124	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—AVP—autistic disorder	2.08e-05	0.000123	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—DHFR—autistic disorder	2.06e-05	0.000122	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—TCN2—autistic disorder	2.05e-05	0.000121	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CACNA1C—autistic disorder	1.96e-05	0.000116	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PLA2G4A—autistic disorder	1.96e-05	0.000116	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ADA—autistic disorder	1.95e-05	0.000116	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—BTD—autistic disorder	1.95e-05	0.000116	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—HTR2A—autistic disorder	1.91e-05	0.000113	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GZMB—autistic disorder	1.85e-05	0.00011	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HTR1B—autistic disorder	1.79e-05	0.000106	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—OXT—autistic disorder	1.79e-05	0.000106	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—DHFR—autistic disorder	1.79e-05	0.000106	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—RORA—autistic disorder	1.78e-05	0.000106	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.73e-05	0.000103	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—HTR2A—autistic disorder	1.73e-05	0.000103	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—PRKCB—autistic disorder	1.67e-05	9.92e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—MAOB—autistic disorder	1.67e-05	9.9e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TSC1—autistic disorder	1.67e-05	9.89e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—DRD1—autistic disorder	1.67e-05	9.89e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—TDO2—autistic disorder	1.66e-05	9.83e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—POMC—autistic disorder	1.65e-05	9.8e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NTRK2—autistic disorder	1.62e-05	9.62e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—DRD3—autistic disorder	1.61e-05	9.58e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—PIK3CG—autistic disorder	1.6e-05	9.49e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IL5—autistic disorder	1.58e-05	9.38e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CALCA—autistic disorder	1.56e-05	9.26e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—DHCR7—autistic disorder	1.56e-05	9.24e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—TPH2—autistic disorder	1.55e-05	9.2e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—DPYD—autistic disorder	1.53e-05	9.05e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—POMC—autistic disorder	1.52e-05	9.04e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PRKCB—autistic disorder	1.52e-05	9.01e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.51e-05	8.97e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—COMT—autistic disorder	1.5e-05	8.88e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GSTP1—autistic disorder	1.49e-05	8.84e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—MAOA—autistic disorder	1.49e-05	8.82e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—EXT1—autistic disorder	1.48e-05	8.76e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SLC6A8—autistic disorder	1.48e-05	8.76e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PIK3CG—autistic disorder	1.45e-05	8.62e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CAT—autistic disorder	1.45e-05	8.6e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CACNA1C—autistic disorder	1.42e-05	8.42e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—DAO—autistic disorder	1.41e-05	8.36e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CYP19A1—autistic disorder	1.4e-05	8.3e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—POMC—autistic disorder	1.38e-05	8.21e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PRL—autistic disorder	1.38e-05	8.18e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PLA2G4A—autistic disorder	1.37e-05	8.12e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GSTM1—autistic disorder	1.37e-05	8.12e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—UPB1—autistic disorder	1.35e-05	8.01e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GPX1—autistic disorder	1.31e-05	7.78e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ADRB2—autistic disorder	1.31e-05	7.76e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—COMT—autistic disorder	1.3e-05	7.71e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSTP1—autistic disorder	1.29e-05	7.68e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—MAOA—autistic disorder	1.29e-05	7.66e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—DHFR—autistic disorder	1.29e-05	7.66e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CAT—autistic disorder	1.26e-05	7.47e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTM5—autistic disorder	1.26e-05	7.45e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ASMT—autistic disorder	1.26e-05	7.45e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—AVP—autistic disorder	1.23e-05	7.29e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IGF2—autistic disorder	1.22e-05	7.26e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—MTHFR—autistic disorder	1.21e-05	7.18e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PLA2G4A—autistic disorder	1.19e-05	7.05e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSTM1—autistic disorder	1.19e-05	7.05e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SLC25A12—autistic disorder	1.18e-05	7e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PLA2G4A—autistic disorder	1.16e-05	6.86e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SLC19A1—autistic disorder	1.15e-05	6.81e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GPX1—autistic disorder	1.14e-05	6.75e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—APOE—autistic disorder	1.13e-05	6.68e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—IL2—autistic disorder	1.13e-05	6.68e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MEF2C—autistic disorder	1.12e-05	6.67e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ITGB3—autistic disorder	1.1e-05	6.5e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—MTHFR—autistic disorder	1.05e-05	6.23e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ADSL—autistic disorder	1.02e-05	6.07e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HTR2A—autistic disorder	1.02e-05	6.07e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—IL2—autistic disorder	1.02e-05	6.07e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PIK3CG—autistic disorder	1.02e-05	6.03e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP19A1—autistic disorder	1.01e-05	6e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—XDH—autistic disorder	1e-05	5.95e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—STX1A—autistic disorder	9.85e-06	5.84e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NPAS2—autistic disorder	9.85e-06	5.84e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—APOE—autistic disorder	9.78e-06	5.8e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TSC2—autistic disorder	9.72e-06	5.77e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—POMC—autistic disorder	9.68e-06	5.74e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—TCN2—autistic disorder	9.51e-06	5.64e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—LEP—autistic disorder	9.51e-06	5.64e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—APOE—autistic disorder	9.51e-06	5.64e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—COMT—autistic disorder	9.4e-06	5.57e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTP1—autistic disorder	9.35e-06	5.55e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—MAOA—autistic disorder	9.33e-06	5.54e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CAT—autistic disorder	9.1e-06	5.4e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ADA—autistic disorder	9.08e-06	5.38e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PRKCB—autistic disorder	8.97e-06	5.32e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PIK3CG—autistic disorder	8.83e-06	5.24e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTM1—autistic disorder	8.59e-06	5.1e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PLA2G4A—autistic disorder	8.59e-06	5.1e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PIK3CG—autistic disorder	8.58e-06	5.09e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—APC—autistic disorder	8.58e-06	5.09e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—EGF—autistic disorder	8.48e-06	5.03e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—POMC—autistic disorder	8.4e-06	4.99e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—RORA—autistic disorder	8.28e-06	4.91e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GPX1—autistic disorder	8.23e-06	4.88e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—POMC—autistic disorder	8.17e-06	4.85e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IGF1—autistic disorder	7.86e-06	4.66e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—MAPK1—autistic disorder	7.82e-06	4.64e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—MAOB—autistic disorder	7.76e-06	4.6e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PTGS2—autistic disorder	7.72e-06	4.58e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—MTHFR—autistic disorder	7.59e-06	4.51e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SERPINE1—autistic disorder	7.46e-06	4.43e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—TPH2—autistic disorder	7.21e-06	4.28e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—DPYD—autistic disorder	7.09e-06	4.21e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—APOE—autistic disorder	7.07e-06	4.2e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PTEN—autistic disorder	6.73e-06	3.99e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PTGS2—autistic disorder	6.7e-06	3.98e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CACNA1C—autistic disorder	6.59e-06	3.91e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PIK3CG—autistic disorder	6.38e-06	3.79e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—HRAS—autistic disorder	6.28e-06	3.73e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—POMC—autistic disorder	6.07e-06	3.6e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IL2—autistic disorder	6.04e-06	3.58e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—IL6—autistic disorder	6.01e-06	3.57e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—DHFR—autistic disorder	6e-06	3.56e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PTEN—autistic disorder	5.84e-06	3.47e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PTEN—autistic disorder	5.68e-06	3.37e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PTGS2—autistic disorder	4.84e-06	2.87e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP19A1—autistic disorder	4.7e-06	2.79e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MAPK1—autistic disorder	4.62e-06	2.74e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—COMT—autistic disorder	4.37e-06	2.59e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTP1—autistic disorder	4.35e-06	2.58e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—MAOA—autistic disorder	4.34e-06	2.57e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CAT—autistic disorder	4.23e-06	2.51e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PTEN—autistic disorder	4.22e-06	2.51e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PLA2G4A—autistic disorder	4e-06	2.37e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTM1—autistic disorder	4e-06	2.37e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GPX1—autistic disorder	3.83e-06	2.27e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HRAS—autistic disorder	3.71e-06	2.2e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IL6—autistic disorder	3.55e-06	2.11e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—MTHFR—autistic disorder	3.53e-06	2.09e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—APOE—autistic disorder	3.29e-06	1.95e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PIK3CG—autistic disorder	2.97e-06	1.76e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—POMC—autistic disorder	2.82e-06	1.68e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PTGS2—autistic disorder	2.25e-06	1.34e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PTEN—autistic disorder	1.96e-06	1.17e-05	CbGpPWpGaD
